Russia will deliver to Uzbekistan 35 million doses of vaccine against a coronavirus

On September 25, 2020 the Russian Direct Investment Fund (RDIF) announced the planned deliveries of 35 million doses of vaccine against a coronavirus "Sputnik of V" to Uzbekistan. The agreement with pharmaceutical company Laxisam was for this purpose signed.

According to the press service of RDIF, after receiving approval of regulating authorities of Uzbekistan in 2020 Russia will be able to deliver up to 10 million doses of vaccine, in the 2021st — 25 million more doses. Financial terms of the contract do not reveal.

World Health Organization and the leading medical specialists in the field of epidemiology of infectious diseases specify that vaccination is efficiently creations of steady immunity for prevention of a dangerous disease of COVID-19 at people — the chairman of the board of Laxisam Group Shavkat Ismailov says. — In this regard the important role belongs to cooperation with RDIF on the vaccine "Sputnik of V" which is created by the Russian scientists based on the advanced scientific and clinical trials.

Russia will deliver to Uzbekistan 35 million doses of vaccine against a coronavirus

According to the head of RDIF Kirill Dmitriyev, supply of vaccine will provide presence at medical specialists in Uzbekistan of the advanced tool for fight against a new koronavirusny infection which allows to create long-term immunity and to secure citizens and also to provide existence of the diversified portfolio of vaccines against a coronavirus. The head of NITsEM of N.F. Gamalei (the developer of the vaccine "Sputnik of V") Alexander Gintsburg promised that medicine will provide immunity from COVID-19 at least within two years.

By the end of September, 2020 of RDIF received purchasing inquiries more than 1.2 billion doses of the vaccine "Sputnik of V" for 2020-2021. Requests directed over 50 CIS countries, Europe, Asia, the Middle East and Latin America. Earlier RDIF announced the reached agreements with partners in Mexico in delivery of 32 million doses, in Brazil — up to 50 million doses and also India — 100 million doses.^[1]

Notes